ELOXX PHARMACEUTICALS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$5.76 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-05-10
- ELOXX PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$5.76M.
- ELOXX PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $924.68K.
- ELOXX PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$208.75K.
- ELOXX PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was -$367.00K.
- ELOXX PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $21.84M.
- ELOXX PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$777.61K.
- ELOXX PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $842.00K.
- ELOXX PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$2.52M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 159 month | Cash and Cash Equivalents, Period Increase (Decrease) 162 month | Cash and Cash Equivalents, Period Increase (Decrease) 165 month | Cash and Cash Equivalents, Period Increase (Decrease) 168 month | Cash and Cash Equivalents, Period Increase (Decrease) 171 month | Cash and Cash Equivalents, Period Increase (Decrease) 174 month | Cash and Cash Equivalents, Period Increase (Decrease) 177 month | Cash and Cash Equivalents, Period Increase (Decrease) 180 month | Cash and Cash Equivalents, Period Increase (Decrease) 183 month | Cash and Cash Equivalents, Period Increase (Decrease) 186 month | Cash and Cash Equivalents, Period Increase (Decrease) 189 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | -$5.76M 10-Q · filed 2018-05-10 | ||||||||||||||
| 2017-12-31 | $21.84M 10-K · filed 2018-03-16 | ||||||||||||||
| 2017-09-30 | $924.68K 10-Q · filed 2017-11-14 | $715.92K derived: sum of 2 quarters · filed 2017-11-14 | $348.92K derived: sum of 3 quarters · filed 2018-05-10 | $211.05K derived: sum of 4 quarters · filed 2018-05-10 | |||||||||||
| 2017-06-30 | -$208.75K derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | -$575.75K derived: sum of 2 quarters · filed 2018-05-10 | -$713.62K derived: sum of 3 quarters · filed 2018-05-10 | -$777.61K 10-K · filed 2017-10-13 | |||||||||||
| 2017-03-31 | -$367.00K 10-Q · filed 2018-05-10 | -$504.87K derived: sum of 2 quarters · filed 2018-05-10 | -$568.86K 10-Q · filed 2017-05-22 | -$1.74M derived: sum of 4 quarters · filed 2018-05-10 | |||||||||||
| 2016-12-31 | -$137.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | -$661.62K 10-Q · filed 2017-02-10 | -$1.38M derived: sum of 3 quarters · filed 2017-11-14 | $842.00K 10-K · filed 2018-03-16 | |||||||||||
| 2016-09-30 | -$523.74K 10-Q · filed 2017-11-14 | -$1.24M derived: sum of 2 quarters · filed 2017-11-14 | -$2.08M derived: sum of 3 quarters · filed 2017-11-14 | -$3.07M derived: sum of 4 quarters · filed 2017-11-14 | |||||||||||
| 2016-06-30 | -$714.79K derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | -$1.56M derived: sum of 2 quarters · filed 2017-10-13 | -$2.54M derived: sum of 3 quarters · filed 2017-10-13 | -$2.52M 10-K · filed 2017-10-13 | |||||||||||
| 2016-03-31 | -$840.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-22 | -$1.83M derived: sum of 2 quarters · filed 2017-05-22 | -$1.81M 10-Q · filed 2017-05-22 | $1.06M derived: sum of 4 quarters · filed 2017-10-13 | |||||||||||
| 2015-12-31 | -$988.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | -$968.05K 10-Q · filed 2017-02-10 | $1.90M derived: sum of 3 quarters · filed 2017-10-13 | -$367.00K 10-K · filed 2018-03-16 | |||||||||||
| 2015-09-30 | $20.24K 10-Q · filed 2016-11-14 | $2.88M derived: sum of 2 quarters · filed 2017-10-13 | $1.25M derived: sum of 3 quarters · filed 2017-10-13 | -$482.27K derived: sum of 4 quarters · filed 2017-10-13 | |||||||||||
| 2015-06-30 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | $1.23M derived: sum of 2 quarters · filed 2017-10-13 | -$502.51K derived: sum of 3 quarters · filed 2017-10-13 | -$2.78M 10-K · filed 2017-10-13 | |||||||||||
| 2015-03-31 | -$1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | -$3.37M derived: sum of 2 quarters · filed 2016-05-12 | -$5.64M 10-Q · filed 2016-05-12 | -$5.73M derived: sum of 4 quarters · filed 2016-10-13 | |||||||||||
| 2014-12-31 | -$1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-16 | -$4.00M 10-Q · filed 2016-02-16 | -$4.09M derived: sum of 3 quarters · filed 2016-10-13 | -$4.01M derived: sum of 4 quarters · filed 2016-10-13 | |||||||||||
| 2014-09-30 | -$2.27M 10-Q · filed 2015-11-16 | -$2.36M derived: sum of 2 quarters · filed 2016-10-13 | -$2.28M derived: sum of 3 quarters · filed 2016-10-13 | $3.05M derived: sum of 4 quarters · filed 2016-10-13 | |||||||||||
| 2014-06-30 | -$86.69K derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | -$10.55K derived: sum of 2 quarters · filed 2016-10-13 | $5.32M derived: sum of 3 quarters · filed 2016-10-13 | $4.51M 10-K · filed 2016-10-13 | |||||||||||
| 2014-03-31 | $76.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-14 | $5.41M derived: sum of 2 quarters · filed 2015-05-14 | $4.60M 10-Q · filed 2015-05-14 | $4.62M derived: sum of 4 quarters · filed 2015-10-09 | $6.20M 10-Q · filed 2014-05-09 | ||||||||||
| 2013-12-31 | $5.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | $4.52M 10-Q · filed 2015-02-17 | $4.54M derived: sum of 3 quarters · filed 2015-10-09 | $5.48M derived: sum of 4 quarters · filed 2015-10-09 | $6.12M 10-Q · filed 2014-02-14 | ||||||||||
| 2013-09-30 | -$813.12K 10-Q · filed 2014-11-14 | -$791.86K derived: sum of 2 quarters · filed 2015-10-09 | $149.05K derived: sum of 3 quarters · filed 2015-10-09 | -$522.88K derived: sum of 4 quarters · filed 2015-10-09 | $604.01K 10-Q · filed 2013-11-14 | ||||||||||
| 2013-06-30 | $21.26K derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-09 | $962.17K derived: sum of 2 quarters · filed 2015-10-09 | $290.24K derived: sum of 3 quarters · filed 2015-10-09 | -$399.03K 10-K · filed 2015-10-09 | $1.60M 10-K · filed 2013-09-11 | ||||||||||
| 2013-03-31 | $940.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-09 | $268.98K derived: sum of 2 quarters · filed 2014-05-09 | -$420.29K 10-Q · filed 2014-05-09 | -$1.63M derived: sum of 4 quarters · filed 2014-09-29 | $1.58M 10-Q · filed 2013-05-15 | ||||||||||
| 2012-12-31 | -$671.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | -$1.36M 10-Q · filed 2014-02-14 | -$2.57M derived: sum of 3 quarters · filed 2014-09-29 | -$912.77K derived: sum of 4 quarters · filed 2014-09-29 | $640.13K 10-Q · filed 2013-02-14 | ||||||||||
| 2012-09-30 | -$689.27K 10-Q · filed 2013-11-14 | -$1.90M derived: sum of 2 quarters · filed 2014-09-29 | -$240.84K derived: sum of 3 quarters · filed 2014-09-29 | -$1.53M derived: sum of 4 quarters · filed 2014-09-29 | $1.31M 10-Q · filed 2012-11-14 | ||||||||||
| 2012-06-30 | -$1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | $448.43K derived: sum of 2 quarters · filed 2014-09-29 | -$840.65K derived: sum of 3 quarters · filed 2014-09-29 | -$1.61M 10-K · filed 2014-09-29 | $2.00M 10-K/A · filed 2012-10-26 | ||||||||||
| 2012-03-31 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | $365.28K derived: sum of 2 quarters · filed 2013-05-15 | -$402.70K 10-Q · filed 2013-05-15 | -$1.65M derived: sum of 4 quarters · filed 2013-09-11 | $3.21M 10-Q · filed 2012-05-14 | ||||||||||
| 2011-12-31 | -$1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14 | -$2.06M 10-Q · filed 2013-02-14 | -$3.31M derived: sum of 3 quarters · filed 2013-09-11 | -$3.28M derived: sum of 4 quarters · filed 2013-09-11 | $1.55M 10-Q · filed 2012-02-14 | ||||||||||
| 2011-09-30 | -$767.98K 10-Q · filed 2012-11-14 | -$2.02M derived: sum of 2 quarters · filed 2013-09-11 | -$2.00M derived: sum of 3 quarters · filed 2013-09-11 | -$3.45M derived: sum of 4 quarters · filed 2013-09-11 | $2.84M 10-Q · filed 2011-11-14 | ||||||||||
| 2011-06-30 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | -$1.23M derived: sum of 2 quarters · filed 2013-09-11 | -$2.68M derived: sum of 3 quarters · filed 2013-09-11 | -$4.42M 10-K · filed 2013-09-11 | |||||||||||
| 2011-03-31 | $23.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-14 | -$1.43M derived: sum of 2 quarters · filed 2012-05-14 | -$3.17M 10-Q · filed 2012-05-14 | ||||||||||||
| 2010-12-31 | -$1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14 | -$3.19M 10-Q · filed 2012-02-14 | |||||||||||||
| 2010-09-30 | -$1.74M 10-Q · filed 2011-11-14 | ||||||||||||||
| 2010-06-30 | $7.65M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |